Status:
RECRUITING
Tools to Identify People At Risk or Already Infected with HIV and HCV
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Collaborating Sponsors:
Consorcio Centro de Investigación Biomédica en Red (CIBER)
European Union
Conditions:
HIV/AIDS
STD
Eligibility:
All Genders
14-65 years
Phase:
NA
Brief Summary
Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to identify People at Risk or already Infected with HIV and HCV
Detailed Description
Objectives: To reduce hidden and incident HIV and HCV infection, through the implementation of a risk and indicator conditions self-questionnaire SQ-R\&IC for HIV and HCV infection, in addition to rap...
Eligibility Criteria
Inclusion
- \- 14-65 years in the health area or who are captured for inclusion by health personnel. They give their consent to participate.
Exclusion
- Having already been included in the study, not signing the consent.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
240000 Patients enrolled
Trial Details
Trial ID
NCT06528626
Start Date
July 1 2023
End Date
December 1 2025
Last Update
March 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria J. Vivancos-Gallego
Madrid, Madrid, Spain, 28034